Search results
Awakn Life Sciences Announces Closing of Tranche of Private Placement. Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), is pleased to announce that ...
See the company profile for Awakn Life Sciences Corp. (AWKNF) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ...
Awakn Life Sciences Corp. operates as a biotechnology company. engages in clinical operations; researching, developing, and delivering psychedelic medicine to better treat Addiction. The firm develops next generation of psychedelic drugs, therapies, and enabling technologies to treat Addiction. The company was founded by Anthony Tennyson ...
ETFs. An ETF Profile page also shows general information about the fund, but also adds information such as a link to the Fund Family. the Underlying Index. Inception Date, First Trade Date, and Leverage. Investment Information Table. The YTD, 1-3- and 5-Year Returns are adjusted for dividends and splits.
366 BAY STREET SUITE 200, TORONTO, Ontario, M5H 4B2, Canada +1 416 361-2517. Awakn Life Sciences Corp is a Canadian biotechnology company with clinical operations researching, developing, and ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Jul 12, 2022 · Awakn Life Sciences Corp. (OTCMKTS: AWKNF) (NEO: AWKN) (FSE: 954) is a revenue-generating biotech company that has completed Phase 2 and is moving into Phase 3 for its lead program.
